TL;DR: PreDxion Bio is a Y Combinator Summer 2017 startup Rapid, scalable diagnostic for SARS-CoV-2 and beyond, currently inactive with a team of 6.
Rapid, scalable diagnostic for SARS-CoV-2 and beyond
Last verified:
PreDxion Bio is working on a rapid saliva-based antigen test for the detection of SARS-CoV-2 S-protein in asymptomatic and presymptomatic patients. Our technology is uniquely capable of being scaled to 10's of millions of tests of days using semiconductor fab processes, a scale of testing necessary to better inform public health officials and policymakers and enable contact tracing at scale. PreDxion Bio's origins are in critical care: our original technology is a rapid, near real-time cytokine and biomarker detection platform to monitor the immune response of critically-ill patients. This technology leverages a novel sensor platform we spun out of the University of Michigan. PreDxion Bio has received FDA Breakthrough Device designation and partnered with top pharmcos to monitor the immun…
Built by LemStudio
Yes. PreDxion Bio was funded by Y Combinator in the Summer 2017 batch. Rapid, scalable diagnostic for SARS-CoV-2 and beyond
PreDxion Bio is working on a rapid saliva-based antigen test for the detection of SARS-CoV-2 S-protein in asymptomatic and presymptomatic patients. Our technology is uniquely capable of being scaled to 10's of millions of tests of days using semiconductor fab processes, a scale of testing necessary to better inform pu…
PreDxion Bio was part of Y Combinator's Summer 2017 batch.
PreDxion Bio has a team of 6 people according to Y Combinator's directory.
PreDxion Bio is currently listed as Inactive with a team of 6 in Y Combinator's directory.
Loading interactive view…